Organovo Holdings, Inc.
ONVO
Rangering i aksjer
#36059
Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering... Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering sophisticated 3D tissues designed to accurately mimic critical facets of human diseases. Central to its operations is a comprehensive 3D human tissue platform, which features the company's proprietary NovoGen Bioprinters. These automated devices are crucial for fabricating complex, living 3D tissues from mammalian cells. The platform also includes supporting technologies necessary for creating specialized "bio-inks" and for the bioprinting of multi-cellular tissues with intricate structures. Organovo supplies specific products, such as ExVive human liver tissue and ExVive human kidney tissue, which are employed for predictive preclinical evaluation of investigational drug compounds. The company was founded in 2007 and maintains its corporate headquarters in Solana Beach, California.
Aksjekurs
$2.00
Sist synkronisert: 2025-05-19
Markedsverdi
$2.93M
Endring (1 dag)
-3.38%
Endring (1 år)
656.14%
Land
US
Handel Organovo Holdings, Inc. (ONVO)
Kategori
Healthcare
Historikk for aksjesplitt for Organovo Holdings, Inc. (ONVO)
Aksjen Organovo Holdings, Inc. (symbol: ONVO) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én ONVO-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 ONVO-aksjer.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én ONVO-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 ONVO-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
